MLchartDataset catalogue

Patent · US3692910A · A · US

Benzylisoquinolinic solutions and method of making the same

(11) Publication number
US3692910A
(22) Filing date
1968-09-05
(30) Priority date
1967-09-07
(43) Publication date
1972-09-19
(45) Date of grant
1972-09-19
(51) IPC
A61K 31/485; A61K 47/18
(52) CPC
  • A61K Preparations for medical, dental or toiletry purposes: 47/18, 31/485, 9/0019
(72) Inventors
Umberto Laguzzi
(54) Title
Benzylisoquinolinic solutions and method of making the same
(57) Abstract

Benzylisoquinolinic solutions and particularly injectable solutions are produced by forming an intimate mixture of appropriate proportions of benzylisoquinolinic compounds, aliphatic alkanol amines which serve as solubilizing agent, a buffer selected from salts of organic acids with alkanol amines or N-methylglucamine, and the proportion of water required to obtain the final solution of the desired concentration of the benzylisoquinolinic compound.

Full text
View on Google Patents

Claims (11)

  1. The method of claim 1 wherein said member (c) is added in an amount whereby said aqueous solution is a pH of from 7.8-8.5.
  2. The method of claim 1 wherein said member (b) additionally contains an anti-oxidant.
  3. A composition comprising an aqueous solution of polyhydroxybenzylisoquinoline or an ester thereof produced by the process of claim 1.
  4. A composition according to claim 4 additionally containing an anti-oxidant.
  5. A compoisition according to claim 5 wherein said anti-oxidant is at least one member selected from the group consisting of butylhydroxyanisol, nordihydroguaiantico and propylgallate.
  6. A composition according to claim 4 wherein said member (c) is a salt with an organic acid selected from the group consisting of citric acid, tartaric acid, succinic acid and maleic acid.
  7. A composition according to claim 7 wherein said member (c) is N-methylglucamine citrate.
  8. A composition according to claim 4 wherein said aqueous solution has a pH of between 7.8 and 8.5.
  9. A composition according to claim 4 wherein said member (b) is present in an amount of 100-200 mg/ml.
  10. A composition according to claim 4 wherein said polyhydroxybenzylisoquinoline is a member selected from the group consisting of 1-(3,4 dioxybenzyl)-6,7 dioxyisoquinoline and 1-(3, 4 dibenzoyloxybenzyl)-6,7 dibenzoyloxyisoquinoline.
  11. A pharmaceutical injectible solution comprising a composition according to claim 4 in dosage unit form.
Record as JSON
{
  "publication_number": "US3692910A",
  "country": "US",
  "kind": "A",
  "title": "Benzylisoquinolinic solutions and method of making the same",
  "abstract": "Benzylisoquinolinic solutions and particularly injectable solutions are produced by forming an intimate mixture of appropriate proportions of benzylisoquinolinic compounds, aliphatic alkanol amines which serve as solubilizing agent, a buffer selected from salts of organic acids with alkanol amines or N-methylglucamine, and the proportion of water required to obtain the final solution of the desired concentration of the benzylisoquinolinic compound.",
  "claims": [
    "2. The method of claim 1 wherein said member (c) is added in an amount whereby said aqueous solution is a pH of from 7.8-8.5.",
    "3. The method of claim 1 wherein said member (b) additionally contains an anti-oxidant.",
    "4. A composition comprising an aqueous solution of polyhydroxybenzylisoquinoline or an ester thereof produced by the process of claim 1.",
    "5. A composition according to claim 4 additionally containing an anti-oxidant.",
    "6. A compoisition according to claim 5 wherein said anti-oxidant is at least one member selected from the group consisting of butylhydroxyanisol, nordihydroguaiantico and propylgallate.",
    "7. A composition according to claim 4 wherein said member (c) is a salt with an organic acid selected from the group consisting of citric acid, tartaric acid, succinic acid and maleic acid.",
    "8. A composition according to claim 7 wherein said member (c) is N-methylglucamine citrate.",
    "9. A composition according to claim 4 wherein said aqueous solution has a pH of between 7.8 and 8.5.",
    "10. A composition according to claim 4 wherein said member (b) is present in an amount of 100-200 mg/ml.",
    "11. A composition according to claim 4 wherein said polyhydroxybenzylisoquinoline is a member selected from the group consisting of 1-(3,4 dioxybenzyl)-6,7 dioxyisoquinoline and 1-(3, 4 dibenzoyloxybenzyl)-6,7 dibenzoyloxyisoquinoline.",
    "12. A pharmaceutical injectible solution comprising a composition according to claim 4 in dosage unit form."
  ],
  "cpc": [
    "A61K 47/18",
    "A61K 31/485",
    "A61K 9/0019"
  ],
  "ipc": [
    "A61K 31/485",
    "A61K 47/18"
  ],
  "inventors": [
    "Umberto Laguzzi"
  ],
  "filing_date": "1968-09-05",
  "publication_date": "1972-09-19",
  "grant_date": "1972-09-19",
  "priority_date": "1967-09-07",
  "application_number": "US-3692910D-A",
  "family_id": "11165135",
  "cited_by_count": 5
}

Record 7,948 of 8,000 in Patents full text (MLC-0201). Request the full dataset.